A model of surface plasmon resonance immunosensor for determining autoantibodies to glutathione-S-transferase in serum samples
- Authors: Ershov P.V1, Kaluzhskiy L.A1, Ivanov A.S1
-
Affiliations:
- Institute of Biomedical Chemistry
- Issue: Vol 18, No 6 (2020)
- Pages: 38-43
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113345
- DOI: https://doi.org/10.29296/24999490-2020-06-06
- ID: 113345
Cite item
Open Access
Access granted
Abstract
Introduction. The quantitative determination and isotyping of autoantibodies to a clinically significant protein - glutathione-S-transferase (GST) in blood serum samples is relevant for monitoring and predicting the dynamics of autoimmune processes. The aim of this study. To adapt an optical biosensor based on surface plasmon resonance (SPR) to detect the interactions of GST and its antibodies in several model experiments using blood serum samples. Methods. The SPR method was used to detect antigen-antibody complexes in the direct, signal enhancement and competitive inhibition assays. Results. For the first time it was shown that there is a principle possibility of SPR analysis for the detection of polyclonal antibodies against GST as an antigen in blood serum samples and isotype determination of bound antibodies with the following immunosensor parameters: a) the immobilization level of GST on a CM5 chip was 4-4.5 ng/mm2; b) the ligand binding capacity decrease after each biosensor cycle, when using 10 mM glycine-HCl (pH 1.5) as an regeneration solution, was 0.1-0.3%; c) linearity range was 30-325 nM; d) the serum content in the analyzed samples was 10% (v/v). Conclusion. Thus, the adaptation of the Biacore SPR biosensors (GE Healthcare, USA) to serial analysis of serum samples to monitor the presence and dynamics of autoantibodies to human body proteins (including GST) opens up new ways for the development of diagnostic tools in biomedical and clinical studies.
Full Text
About the authors
P. V Ershov
Institute of Biomedical Chemistry
Email: pavel79@inbox.ru
senior researcher Institute of Biomedical Chemistry, PhD Pogodinskaya str., 10, Bld. 8, Moscow, 119121, Russian Federation
L. A Kaluzhskiy
Institute of Biomedical Chemistry
Email: leonid.kaluzhskiy@ibmc.msk.ru
researcher Institute of Biomedical Chemistry, PhD Pogodinskaya str., 10, Bld. 8, Moscow, 119121, Russian Federation
A. S Ivanov
Institute of Biomedical Chemistry
Email: alexei.ivanov@ibmc.msk.ru
Head of the laboratory Institute of Biomedical Chemistry, Professor, doctor of biological Sciences Pogodinskaya str., 10, Bld. 8, Moscow, 119121, Russian Federation
References
- Иванов А.С. Исследование межмолекулярных взаимодействий с помощью оптических биосенсоров, работающих на эффекте поверхностного плазмонного резонанса. Современные технологии в медицине. 2012; 4: 142-53
- Rich R.L., Myszka D.G. Why you should be using more SPR biosensor technology Drug Discov Today Technol. 2004; 1 (3): 301-8. https://doi.org/10.10167j.dd-tec.2004.09.009.
- Mariani S., Minunni M. Surface plasmon resonance applications in clinical analysis. Anal. Bioanal. Chem. 2014; 406 (9-10): 2303-23. https://doi.org/10.1007/s00216-014-7647-5.
- Оценка иммуногенности терапевтических белков, полученных с использованием биотехнологических методов (гл. 11). Решение Совета Евразийской экономической комиссии от 3 ноября 2016 г. №89 «Об утверждении Правил проведения исследований биологических лекарственных средств Евразийского экономического союза».
- FDA Draft: Guidance for Industry - Assay Development and Validation for Immunogenicity Testing of Therapeutic Protein Products. 2016.
- FDA-2009-D-0539-0054 «Immunogenicity Testing of Therapeutic Protein Products Developing and Validating Assays for AntiDrug Antibody Detection». Federal Register on February 1. 2019.
- EMEA/CHMP/BMWP/14327/2006 Rev 1. Committee for Medicinal Products for Human Use (CHMP) «Guideline on Immunogenicity assessment of therapeutic proteins». 2017.
- European Pharmacopoeia Department (European Directorate for the Quality of Medicines & Health) «The role of European Pharmacopoeia monographs in setting quality standards for biotherapeuticprod-ucts». 2016.
- Kato T., Miyakawa H., Ishibashi M. Frequency and significance of antiglutathione S-transferase autoantibody (anti-GST A1-1) in autoimmune hepatitis. J. Autoimmun. 2004; 22 (3): 211-6. https://doi. org/10.1016/j.jaut.2004.01.003.
- Yang J., Tezel G., Patil R.V., Romano C., Wax M.B. Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest. Ophthalmol. Vis. Sci. 2001; 42 (6): 1273-6.
- Wesierska-Gadek J., Grimm R., Hitchman E., Penner E. Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis. Gastroenterology 1998; 114 (2): 329-35. https://doi. org/10.1016/s0016-5085(98)70485-8
- Мальцева Н.В., Лыкова О.Ф., Мельниченко М.А., Архипова С.В., Онищенко А.Л. Зависимость содержания иммуноглобулинов IgA и IgE в слезной жидкости от полиморфизмов гена глутатион-трансферазы у металлургов с офтальмопатологией. Медицинская иммунология. 2011; 13 (6): 609-16.
- Patent for the invention (RU2012147551) Methods for diagnostic of glaucoma. F. Cargo, N. Boehm, P. Norbert, K. Bel. 2014. https://patentscope.wipo.int/
- Jaki T., Lawo J.P., Wolfsegger M.J., Singer J., Allacher P., Horling F. A formal comparison of different methods for establishing cut points to distinguish positive and negative samples in immunoassays. J. Pharm. Biomed. Anal. 2011; 55 (5): 1148-56. https:// doi.org/10.1016/j.jpba.2011.04.006.
Supplementary files
